Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Cremer

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Iscience|November 25, 2024
Tumor stage-driven disruption of NK cell maturation in human and murine tumorsJules Russick, Carine Torset, Dan Sun, et al.
Oncoimmunology|May 4, 2018
Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcomeVéronique M Braud, Jérôme Biton, Etienne Becht, et al.
Journal for Immunotherapy of Cancer|November 22, 2019
Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patientsLenka Kasikova, Michal Hensler, Iva Truxova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2019
Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung TumorsAudrey Mansuet-Lupo, Marc Barritault, Marco Alifano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2018
<i>TP53, STK11</i>, and <i>EGFR</i> Mutations Predict Tumor Immune Profile and the Response to Anti-PD-1 in Lung AdenocarcinomaJérôme Biton, Audrey Mansuet-Lupo, Nicolas Pécuchet, et al.
Cancer Research|November 15, 2013
Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanomaMeriem Messaoudene, Giulia Fregni, Emmanuelle Fourmentraux-Neves, et al.
Chest|March 29, 2014
The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohortAudrey Mansuet-Lupo, Antonio Bobbio, Hélène Blons, et al.
American Journal of Respiratory and Critical Care Medicine|February 4, 2014
Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancerClaire Germain, Sacha Gnjatic, Fella Tamzalit, et al.
Frontiers in Immunology|July 29, 2021
Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized MedicineJules Russick, Pierre-Emmanuel Foy, Nathalie Josseaume, et al.
Cancer Research|December 25, 2013
Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cellsJérémy Goc, Claire Germain, Thi Kim Duy Vo-Bourgais, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Iscience|November 25, 2024
Tumor stage-driven disruption of NK cell maturation in human and murine tumorsJules Russick, Carine Torset, Dan Sun, et al.
Oncoimmunology|May 4, 2018
Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcomeVéronique M Braud, Jérôme Biton, Etienne Becht, et al.
Journal for Immunotherapy of Cancer|November 22, 2019
Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patientsLenka Kasikova, Michal Hensler, Iva Truxova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2019
Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung TumorsAudrey Mansuet-Lupo, Marc Barritault, Marco Alifano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2018
<i>TP53, STK11</i>, and <i>EGFR</i> Mutations Predict Tumor Immune Profile and the Response to Anti-PD-1 in Lung AdenocarcinomaJérôme Biton, Audrey Mansuet-Lupo, Nicolas Pécuchet, et al.
Cancer Research|November 15, 2013
Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanomaMeriem Messaoudene, Giulia Fregni, Emmanuelle Fourmentraux-Neves, et al.
Chest|March 29, 2014
The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohortAudrey Mansuet-Lupo, Antonio Bobbio, Hélène Blons, et al.
American Journal of Respiratory and Critical Care Medicine|February 4, 2014
Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancerClaire Germain, Sacha Gnjatic, Fella Tamzalit, et al.
Frontiers in Immunology|July 29, 2021
Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized MedicineJules Russick, Pierre-Emmanuel Foy, Nathalie Josseaume, et al.
Cancer Research|December 25, 2013
Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cellsJérémy Goc, Claire Germain, Thi Kim Duy Vo-Bourgais, et al.
Pageof 10